Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02752789 · ClinicalTrials.gov registry record
Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function
A clinical trial of Pediatric Heart Transplantation and Pediatric Heart Transplant Recipients, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 407
- Enrollment target
- 9
- Study locations
NCT02752789 is a study of Pediatric Heart Transplantation and Pediatric Heart Transplant Recipients that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 407 participants. The trial reports 9 study locations across 7 states.
The verdict
NCT02752789, a study of Pediatric Heart Transplantation and Pediatric Heart Transplant Recipients, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 407 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is a multi-center, prospective, single cohort, observational study of pediatric heart transplant recipients designed to determine the impact of preformed versus de novo human leukocyte antigen (HLA) donor-specific antibodies (DSA), and antibodies to the self-antigens cardiac myosin and vimentin, on chronic allograft function. In addition, the investigators will explore mechanisms of action and predictors of DSA, rejection and altered pathophysiology.
Conditions Studied
Study Locations (9)
New York
- Columbia University Medical Center - New York
- Children's Hospital at Montefiore - New York
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- Children's Hospital of Pittsburgh - Pittsburgh
Georgia
- Emory University School of Medicine - Atlanta
Massachusetts
- Children's Hospital Boston - Boston
Missouri
- St. Louis Children's Hospital - St Louis
Tennessee
- Monroe Carell Jr. Children's Hospital - Nashville
Other
- Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 407 participants |
| Start Date | 2014-07-15 |
| Est. Completion | 2019-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02752789
The ClinicalTrials.gov registry entry for NCT02752789 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 407 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pediatric Heart Transplantation appearing as the primary indexed condition, and to 0 interventions.
NCT02752789 reports 9 study locations spanning 7 distinct geographic areas - top geographies include New York, Pennsylvania, Georgia.
Frequently Asked Questions
What is clinical trial NCT02752789 about?
NCT02752789 is a clinical study titled "Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function". This is a multi-center, prospective, single cohort, observational study of pediatric heart transplant recipients designed to determine the impact of preformed versus de novo human leukocyte antigen (HLA) donor-specific antibodies (DSA), and antibodies to the self-antigens cardiac myosin and vimentin...
What is the current status of trial NCT02752789?
This trial is currently completed. The enrollment target is 407 participants. The study started on 2014-07-15. Estimated completion is 2019-11-01.
What conditions does trial NCT02752789 study?
This clinical trial studies the following conditions: Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients.
Who is sponsoring clinical trial NCT02752789?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02752789 being conducted?
This trial has 9 study locations across Georgia, Massachusetts, Missouri, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Pediatric Heart Transplantation
All registered trials for this condition
Pediatric Heart Transplant Recipients
All registered trials for this condition
Georgia
All trials with a study site in Georgia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.